Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial

Livingstone Tavul, Moses Laman, Cade Howard, Bethuel Kotty, Anna Samuel, Catherine Bjerum, Kobie O’brian, Steven Kumai, Matthew Amuga, Lina Lorry, Zebedee Kerry, Melvin Kualawi, Stephan Karl, Leo Makita, Lucy N. John, Sibauk Bieb, James Wangi, Gary J. Weil, Charles W. Goss, Daniel J. TischWilliam Pomat, Christopher L. King, Leanne J. Robinson

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences